Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LENZ Therapeutics (LENZ) Other Non Operating Income (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Other Non Operating Income for 4 consecutive years, with -$417000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 5312.5% to -$417000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$243000.0 through Dec 2025, down 184.08% year-over-year, with the annual reading at -$243000.0 for FY2025, 184.08% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$417000.0 at LENZ Therapeutics, down from -$14000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $2.2 million in Q4 2022, with the low at -$1.3 million in Q1 2024.
  • Average Other Non Operating Income over 4 years is $297333.3, with a median of -$6000.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income surged 9183.33% in 2024, then plummeted 5312.5% in 2025.
  • Over 4 years, Other Non Operating Income stood at $2.2 million in 2022, then tumbled by 104.69% to -$101000.0 in 2023, then soared by 107.92% to $8000.0 in 2024, then tumbled by 5312.5% to -$417000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$417000.0, -$14000.0, and $199000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.